Axsome Therapeutics Inc. Watch

from 10-Q 9 pages Axsome Therapeutics, Inc. Stock Unit Notice Under the Axsome Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan

from 10-Q 9 pages Axsome Therapeutics, Inc. Stock Unit Notice Under the Axsome Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan

from 10-Q 7 pages Axsome Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan Nonqualified Stock Option Summary of Grant

from 10-K 14 pages Axsome Therapeutics, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan

from 8-K 8 pages Purpose. This Plan Is Intended to Provide Employees of the Company and Its Participating Subsidiaries With an Opportunity to Acquire a Proprietary Interest in the Company Through the Purchase of Shares of Common Stock. the Company Intends That the Plan Qualify as an “Employee Stock Purchase Plan” Under Section 423 of the Code and the Plan Shall Be Interpreted in a Manner That Is Consistent With That Intent. 3. Definitions. “Board or Board of Directors” Means the Board of Directors of the Company, as Constituted From Time to Time. “Business Day” Means Any Regularly Scheduled Trading Day of the New York Stock Exchange. “Code” Means the U.S. Internal Revenue Code of 1986, as It May Be Amended From Time to Time. Any Reference to a Section of the Code Shall Be Deemed to Include a Reference to Any Regulations Promulgated Thereunder. “Committee” Means the Compensation Committee of the Board of Other Committee Appointed by the Board to Administer the Plan. “Common Stock” Means the Common Stock of the Company, Par Value $.0001 Per Share. “Company” Means Axsome Therapeutics, Inc., a Delaware Corporation, Including Any Successor Thereto

from 10-Q 40 pages Whereas, Terms Used but Not Otherwise Defined Herein Shall Have the Meanings Ascribed Thereto in the Lease. Now, Therefore, in Consideration of the Mutual Covenants Herein Contained, Sublandlord and Subtenant Agree as Follows: 1. Demise; Term

from 10-Q 47 pages License Agreement

from 10-Q 21 pages Share Transfer Agreement

from 10-Q 16 pages Warrant Agreement to Purchase Shares of the Common Stock of Axsome Therapeutics, Inc. Dated as of [  ]

from 10-Q Pdf Courtesy Copy

from 10-Q/A 10 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Not Material and Would Likely Cause Competitive Harm to the Company if Publicly Disclosed. [***] Indicates That Information Has Been Redacted. ​

from 10-Q 12 pages ​ Direct Agreement

from 10-Q 15 pages Warrant Agreement ​ to Purchase Shares of the Common Stock of ​ Axsome Therapeutics, Inc. ​ Dated as of September 25, 2020

from 10-Q 102 pages Agreement

from 10-Q 16 pages ​ Axsome Therapeutics, Inc. Amended and Restated 2015 Omnibus Incentive Compensation Plan

from 10-Q 26 pages Membership Details Form

from 10-K 7 pages Axsome Therapeutics, Inc. Stock Unit Notice Under the Axsome Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan

from 10-K 46 pages License Agreement

from 8-K 25 pages Share Transfer Agreement

from 8-K 11 pages Warrant to Purchase Stock